| Name | Title | Contact Details |
|---|
Precision Machining & World-Wide Distribution Center Paragon is a World Class Global Precision Supplier specializing in the Machining and Assembly of Ferrous / Non Ferrous Components for the Automotive and Non Automotive Industries. Our Customers experience Superior Quality, Competitive Cost, and Attentive Service.
Ayesa is a global provider of technology and engineering services with more than 11500 employees in twenty-three countries across Europe, Latin America, Africa and Asia. The company develops and implements digital solutions for the private and public sector and uses the latest technology to provide cutting-edge infrastructure design and supervision services. To do this, it has certified experts covering more than 70 different disciplines in utilities and energy; the public sector; banking and insurance; water and the environment, transportation; aeronautics and defence; and construction. As a company that is driven by people and innovation, its business approach is underpinned by talent.
Western States Equipment Company, known as Western States Cat, is a prominent heavy equipment dealer and service provider in the Northwest U.S. Established in 1933, the company has evolved from its origins in construction to specialize in equipment sales and service. It operates across a vast area of over 191,000 square miles, including Idaho, Eastern Washington, Oregon, Western Montana, and Wyoming, with 17 branches and 15 Cat® Rental Stores. The company offers a range of services, including the sale of new and used heavy equipment, short- and long-term rentals of various machinery, and comprehensive maintenance and repair services. They provide genuine Cat® parts and accessories, ensuring quick sourcing and delivery. Western States Cat serves commercial and industrial clients, focusing on construction, mining, and infrastructure development, and emphasizes personalized service and tailored financing solutions for its customers.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.